Vascon Engineers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 4, 2025, 5:24 pm

Quick Insight

Vascon Engineers Ltd's current share price of ₹55.9 seems undervalued with a P/E ratio of 16.1, indicating potential for growth. However, the company's ROE and ROCE at 6.24% and 7.56% respectively are below industry averages, suggesting inefficiencies in capital utilization. The low OPM at 10% raises concerns about profitability sustainability, despite a healthy Net Profit of ₹130 Cr. The high promoter holding of 30.93% provides some stability, but the lack of FII and DII interest may limit market confidence. With a P/BV of 0.76x and a comfortable ICR of 5.32x, Vascon Engineers should focus on improving operational efficiency and investor engagement to unlock its true intrinsic value and drive shareholder returns in the long term.

Competitors of Vascon Engineers Ltd

All Competitor Stocks of Vascon Engineers Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:22 am

Below is a detailed analysis of the quarterly data for Vascon Engineers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 387.00 Cr.. The value appears strong and on an upward trend. It has increased from 295.00 Cr. (Dec 2024) to 387.00 Cr., marking an increase of 92.00 Cr..
• For Expenses, as of Mar 2025, the value is 350.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 275.00 Cr. (Dec 2024) to 350.00 Cr., marking an increase of 75.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Dec 2024) to 37.00 Cr., marking an increase of 17.00 Cr..
• For OPM %, as of Mar 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Dec 2024) to 10.00%, marking an increase of 3.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 72.00 Cr..
• For Interest, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
• For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Dec 2024) to 37.00 Cr., marking a decrease of 54.00 Cr..
• For Tax %, as of Mar 2025, the value is 6.00%. The value appears to be improving (decreasing) as expected. It has decreased from 17.00% (Dec 2024) to 6.00%, marking a decrease of 11.00%.
• For Net Profit, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Dec 2024) to 35.00 Cr., marking a decrease of 41.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.54. The value appears to be declining and may need further review. It has decreased from 3.34 (Dec 2024) to 1.54, marking a decrease of 1.80.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:51 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:07 am

Below is a detailed analysis of the balance sheet data for Vascon Engineers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 226.00 Cr.. The value appears strong and on an upward trend. It has increased from 221.00 Cr. (Mar 2024) to 226.00 Cr., marking an increase of 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 867.00 Cr.. The value appears strong and on an upward trend. It has increased from 760.00 Cr. (Mar 2024) to 867.00 Cr., marking an increase of 107.00 Cr..
• For Borrowings, as of Mar 2025, the value is 206.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 194.00 Cr. (Mar 2024) to 206.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 687.00 Cr. (Mar 2024) to 830.00 Cr., marking an increase of 143.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,862.00 Cr. (Mar 2024) to 2,128.00 Cr., marking an increase of 266.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2024) to 74.00 Cr., marking a decrease of 52.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,969.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,652.00 Cr. (Mar 2024) to 1,969.00 Cr., marking an increase of 317.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,128.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,862.00 Cr. (Mar 2024) to 2,128.00 Cr., marking an increase of 266.00 Cr..

Notably, the Reserves (867.00 Cr.) exceed the Borrowings (206.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Vascon Engineers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.81. This value is within the healthy range. It has increased from 3.05 (Mar 24) to 5.81, marking an increase of 2.76.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.81. This value is within the healthy range. It has increased from 3.05 (Mar 24) to 5.81, marking an increase of 2.76.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.74. This value is below the healthy minimum of 3. It has decreased from 3.72 (Mar 24) to 2.74, marking a decrease of 0.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.29. It has increased from 44.94 (Mar 24) to 48.29, marking an increase of 3.35.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.29. It has increased from 44.94 (Mar 24) to 48.29, marking an increase of 3.35.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 47.63. It has increased from 47.57 (Mar 24) to 47.63, marking an increase of 0.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.44. This value is within the healthy range. It has decreased from 4.87 (Mar 24) to 4.44, marking a decrease of 0.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.18. This value is within the healthy range. It has decreased from 4.22 (Mar 24) to 4.18, marking a decrease of 0.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.32. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.32, marking a decrease of 0.18.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 2.48, marking a decrease of 0.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.75. This value is within the healthy range. It has increased from 3.02 (Mar 24) to 5.75, marking an increase of 2.73.
• For PBDIT Margin (%), as of Mar 25, the value is 9.31. This value is below the healthy minimum of 10. It has decreased from 10.24 (Mar 24) to 9.31, marking a decrease of 0.93.
• For PBIT Margin (%), as of Mar 25, the value is 8.76. This value is below the healthy minimum of 10. It has decreased from 8.87 (Mar 24) to 8.76, marking a decrease of 0.11.
• For PBT Margin (%), as of Mar 25, the value is 6.97. This value is below the healthy minimum of 10. It has decreased from 7.36 (Mar 24) to 6.97, marking a decrease of 0.39.
• For Net Profit Margin (%), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 5.21, marking a decrease of 1.24.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.08. This value is within the healthy range. It has increased from 6.35 (Mar 24) to 12.08, marking an increase of 5.73.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.91. This value is below the healthy minimum of 15. It has increased from 6.81 (Mar 24) to 11.91, marking an increase of 5.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.82. This value is below the healthy minimum of 10. It has decreased from 8.52 (Mar 24) to 7.82, marking a decrease of 0.70.
• For Return On Assets (%), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 6.11, marking an increase of 2.52.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.18, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.54. It has decreased from 0.59 (Mar 24) to 0.54, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 1.89, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.25, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.71, marking an increase of 1.71.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.12 (Mar 24) to 0.00, marking a decrease of 8.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.68 (Mar 24) to 0.00, marking a decrease of 6.68.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.88 (Mar 24) to 0.00, marking a decrease of 91.88.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.32 (Mar 24) to 0.00, marking a decrease of 93.32.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.32. This value is within the healthy range. It has decreased from 6.77 (Mar 24) to 5.32, marking a decrease of 1.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.80. This value is within the healthy range. It has decreased from 5.27 (Mar 24) to 3.80, marking a decrease of 1.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 817.47. It has decreased from 1,460.70 (Mar 24) to 817.47, marking a decrease of 643.23.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
• For EV / EBITDA (X), as of Mar 25, the value is 8.14. This value is within the healthy range. It has decreased from 13.55 (Mar 24) to 8.14, marking a decrease of 5.41.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.77, marking a decrease of 0.52.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.87 (Mar 24) to 0.00, marking a decrease of 91.87.
• For Price / BV (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 1.38 (Mar 24) to 0.76, marking a decrease of 0.62.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.77, marking a decrease of 0.52.
• For EarningsYield, as of Mar 25, the value is 0.15. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.15, marking an increase of 0.11.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness